{
    "Trade/Device Name(s)": [
        "Alere i Influenza A & B",
        "Alere i Influenza A & B Control Swab Kit",
        "Alere i Instrument",
        "Alere i flu",
        "Alere i",
        "Alere Influenza A & B"
    ],
    "Submitter Information": "Alere Scarborough, Inc.",
    "510(k) Number": "K163266",
    "Predicate Device Reference 510(k) Number(s)": [
        "K151464"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OZE",
        "OOI"
    ],
    "Summary Letter Date": "November 18, 2016",
    "Summary Letter Received Date": "November 21, 2016",
    "Submission Date": "November 18, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay",
        "Instrumentation for Clinical Multiplex Test Systems"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A viral RNA",
        "Influenza B viral RNA"
    ],
    "Specimen Type(s)": [
        "Direct nasal swab",
        "Nasal swab",
        "Nasopharyngeal swab eluted in viral transport media"
    ],
    "Specimen Container(s)": [
        "Viral transport media"
    ],
    "Instrument(s)/Platform(s)": [
        "Alere i Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Isothermal nucleic acid amplification"
    ],
    "Methodologies": [
        "Molecular testing",
        "Nucleic acid amplification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "Control Swab Kit",
        "Reader",
        "Reagent",
        "Cartridge",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for Alere i Influenza A & B rapid molecular test using isothermal nucleic acid amplification for detection and discrimination of influenza A and B viral RNA",
    "Indications for Use Summary": "Qualitative detection and discrimination of influenza A and B viral RNA in nasal and nasopharyngeal swabs from symptomatic patients to aid differential diagnosis of influenza A and B infections, intended for use with the Alere i Instrument",
    "fda_folder": "Microbiology"
}